Endometriosis-Associated Pain

Endometriosis Pain: Pathophysiology - Rogue Tissue Riot

• Ectopic Tissue: Endometrial glands & stroma outside uterus, estrogen-sensitive.
• Inflammatory Milieu: Core of pain.
  • Cyclical bleeding from implants → sterile inflammation.
  • ↑ Prostaglandins (e.g., $PGE_2$, $PGF_{2\alpha}$), cytokines (e.g., TNF-α, IL-1β, IL-6), chemokines.
  • Activated immune cells (macrophages, mast cells).
• Neurogenic Inflammation & Angiogenesis:
  • ↑ Nerve Growth Factor (NGF) → sensory nerve fiber sprouting (hyperinnervation).
  • New vessel growth sustains lesions.
• Pain Sensitization:
  • Peripheral: Nociceptors become hypersensitive.
  • Central: CNS amplifies pain signals (allodynia, hyperalgesia).
• Structural Distortion:
  • Adhesions, fibrosis, scarring.
  • Nerve compression/infiltration by lesions.
  • Endometriomas (ovarian "chocolate cysts").

⭐ Increased Nerve Growth Factor (NGF) in peritoneal fluid is strongly linked to endometriosis-associated pain severity and lesion hyperinnervation.

Endometriosis Pain: Diagnosis - Unmasking Misery

• Clinical Presentation:
  • Cyclical pelvic pain (dysmenorrhea), often progressive.
  • Deep dyspareunia.
  • Chronic pelvic pain (CPP > 6 months).
  • Dyschezia, dysuria (if bowel/bladder involved).
  • Subfertility or infertility.
• Key Examination Findings:
  • Pelvic tenderness (non-specific).
  • Uterosacral ligament nodularity, thickening, or tenderness.
  • Adnexal mass (endometrioma).
  • Fixed, retroverted uterus.
• Investigations:
  • Transvaginal Sonography (TVS):
    • First-line imaging modality.
    • Identifies endometriomas (homogenous, low-level echogenicity - "ground glass" appearance).
    • May suggest Deep Infiltrating Endometriosis (DIE) or adenomyosis.
  • MRI:
    • Useful for complex cases, extensive DIE, or when TVS is inconclusive.
    • Aids in pre-operative mapping.
  • Laparoscopy:
    • Gold standard for definitive diagnosis.
    • Allows direct visualization of lesions (e.g., powder-burn, clear, red, blue-black, white opacifications, adhesions, endometriomas).
    • Enables biopsy for histological confirmation (presence of endometrial glands and stroma).

⭐ Laparoscopy with histological confirmation is the gold standard for diagnosing endometriosis, allowing for simultaneous diagnosis and potential treatment.

Endometriosis Pain: Management - Calming the Chaos

Goal: Alleviate pain, improve QoL, preserve fertility if desired. Stepwise, individualized management.

• Pharmacological Therapy:
  • NSAIDs: Mild pain (e.g., Mefenamic acid, Ibuprofen).
  • Combined Oral Contraceptives (COCs): Continuous regimen for amenorrhea, ovulation suppression.
  • Progestins:
    • Dienogest (2 mg/day).
    • Norethisterone acetate (5-15 mg/day).
    • MPA (depot/oral).
  • GnRH Agonists: (Leuprolide, Goserelin)
    • Pseudomenopause; use "add-back" (E+P) to ↓ side effects (bone loss, vasomotor). Max 6-12 months.
  • GnRH Antagonists: (Elagolix) Oral, dose-dependent estradiol suppression.
  • Danazol: Androgenic side effects limit use.
• Surgical Management:
  • Conservative: Laparoscopic excision/ablation of implants, adhesiolysis. For Dx, pain relief, fertility enhancement.
  • Definitive: TAH+BSO for severe, refractory pain (childbearing complete).
• Adjunctive Therapies: Physiotherapy, TENS, acupuncture, lifestyle modifications.

⭐ Dienogest 2 mg/day is an effective oral progestin for endometriosis-associated pain, often chosen for its balance of efficacy and tolerability, avoiding severe hypoestrogenic effects seen with GnRH agonists alone.

High‑Yield Points - ⚡ Biggest Takeaways

• Chronic pelvic pain, dysmenorrhea, and dyspareunia are classic symptoms.
• Retrograde menstruation is the most accepted etiological theory.
• Ovaries are the most common site, often with endometriomas ('chocolate cysts').
• Laparoscopy with biopsy is the gold standard for diagnosis.
• Look for powder-burn lesions, adhesions, and blue-black ('mulberry') spots.
• Management: NSAIDs, hormonal therapy (OCPs, GnRH agonists), and surgery.
• Strong association with infertility and subfertility.